January 08, 2001 Issue




COVER
  The Genius of Anand
Finally, India has a world champion. And that in a game played in 156 countries, not eight. The story of Grandmaster Vishwanathan Anand's rise from rookie to king.


 
THE NATION
 

Hideouts of Terror
The relative ease with which the Lashkar-e-Toiba's jehadis were able to penetrate into the heart of Delhi is a pointer to the networks of support that the ISI has created throughout India.

 
STATES
 

Separated at Berth
Partition has resulted in squabbles over sharing of people and resources.

 
Columns
 

Fifth Column
by Tavleen Singh
Year of Inaction

 
  Kautilya
by Jairam Ramesh
New Set of Fiscal Rules

 
 

Right Angle
by Swapan Dasgupta
Awaiting the Backlash

 
Other stories
  Economy  
  Defence  
  Neighbours  
  Lifestyle  
  Cinema  
  Entertainment  
  Music  
  Health  
NewsNotes
 

Friendly Foes

 
 

Secular Show

More...

 
 



 
  Home  
 

HEALTH WA+CH

Remedial Rays

Phototherapy makes light of common skin diseases that blight many lives

Ancient Indians believed in the healing powers of sunlight. Modern India had for long ignored its therapeutic value in favour of chemical treatments. Now light-based phototherapy is back as modern medicine's potent weapon against common but socially devastating skin diseases like leucoderma (white patches in the skin), eczema, psoriasis (scaly lesions) and pruritis (itching). Leucoderma, for example, affects 1-2 per cent of the world population, many of them (approximately 8 per cent) Indian, and has no known cause. Until now, it didn't have a cure either. The disease is not contagious but the scars of social ostracism can be deep and damaging.

With more than eight out of 10 patients cured, phototherapy has an impressive record. Not only that, newer techniques are also coming into vogue. Says R.K. Joshi, a consultant at Delhi's Apollo Hospital: "More and more people are coming for phototherapy." At Rs 200-500 per sitting, relative affordability contributes to its popularity. The treatment can last from a few weeks to a few months, according to S.K. Bharija of Delhi's Ganga Ram Hospital.

Phototherapy utilises in a more measured and controlled pattern the ultraviolet (UV) rays that occur naturally in sunlight. The rays are medically multifunctional-their anti-inflammatory qualities act against eczema, dermatitis and itching. They also banish the ugly scales of psoriasis by preventing cell proliferation. But the rays are most popular as promoters of pigments that colour the incriminating pale patches of leucoderma. After applying psorelen, a chemical that makes the body sensitive to light, the affected part is exposed to UV rays. Psorelen can either be applied on the affected region, or, for larger areas, taken orally. Since September this year Apollo Hospital has offered bath psorelen treatment for systemic ailments. The gentler UV-a ray treatment has been used during the past decade, but takes longer to show results. Short, sharp doses of the more intense UV-B rays is the latest line of treatment that has been made available in India recently. UV-B is particularly effective in patients with acne and pruritis.

In the West, UV light has been reported to cause skin cancer, but Indians, being darker, are rarely at risk, says Joshi. According to him, the treatment is safe as long as precautions are taken to protect vulnerable regions, and proper doses are implemented. However, Bharija warns that long-term exposure without protection can lead to premature cataract. UV-a-cured leucoderma patient Raj Khurana is unfazed. After a lifetime of misery, this summer he can finally wear short sleeves without fear of repulsion.

-Supriya Bezbaruah

In Small Doses

Old Drugs to the Rescue: Ancient remedies might come to the rescue of anaemics, a tribe that includes the majority of Indian women. Iron supplements help when low iron levels are the cause. But ruptured red blood cells (RBCs) can sometimes be the problem. Now Indian scientists report that three ayurvedic medicines - raktabardhak, punarnavasav and navayaslough - are effective in preventing a type of anaemia, haemolytic anaemia, in which the rbcs get broken down. All three drugs have been shown to prevent the destruction of these cells in the spleen.

Pets and Stress: Stressed? What you need is a dog. Pets, particularly dogs, reduce cardiovascular stress. A study monitored the effect of dogs on 60 volunteers with hypertension. In the absence of dogs, volunteers reacted similarly to simulated stress situations whereas the group with pets showed little signs of hypertension. Looks like canine is the way to calm.

Rhythm Out of Sync: For years, those in favour of natural birth control systems followed the "rhythm method", based on the knowledge that the average woman is only fertile between days 10 to 17 of her menstrual cycle. Now a British study clearly says that method simply doesn't work. The study was conducted on more than 200 women with regular cycles aged 25-35 years, using a variety of biochemical tests, including hormone levels in daily urine samples. Most volunteers were potentially fertile every day of the month. The situation could be even more unpredictable in teenagers. So timing isn't everything.

Top
 
 
 
     METRO TODAY
  MetroScape  
   


MetroScape
Fastest Fella First
After Swar Utsav, CP hosted another non-mercantile event—the first ever National Karting Championship that challenged 14 winners from seven regional finals.
more...

Looking Glass

Mumbai: Restaurant

Mumbai: Exhibition

Mumbai: Magazine

Delhi: Bar

Delhi: Store

 
    Web Exclusives
COLUMNS  



Among the major spin-offs of developing the LCA is the mountain of confidence that India's aeronautical engineers have gained. But there's still plenty to do, writes INDIA TODAY Deputy Editor Raj Chengappa in 21 Up.

 
DESPATCHES  



The 80th birthday do of a social reformer shows how the lives of entire communites in coastal Gujarat have changed for the better. INDIA TODAY Principal Correspondent Uday Mahurkar reports in Despatches.


 

 

PREVIOUS ISSUE



Click here to view
the previous issue

 
CONTACT US SUBSCRIPTION PRIVACY POLICY